Biotech T-MAXIMUM Pharmaceutical’s Allogeneic CAR-T Therapy MT027 Receives FDA IND Clearance to Proceed to Phase II clinical Trial for Recurrent Glioblastoma December 22, 2025
Biotech New York State’s 2025 Emerging Technology Advisory Board Releases Final Report to Boost Biotech Innovation, Commercialization and Public Health Impact December 21, 2025
Biotech Boehringer Ingelheim announces broad agreement with the U.S. Government to lower the cost of medicines for American patients and expand its U.S. footprint December 20, 2025
Biotech Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology December 17, 2025
Biotech Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Induction Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on December 16, 2025 December 16, 2025
Biotech Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor December 15, 2025
Biotech Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout December 14, 2025
Biotech NanOlogy Unveils Drug Development Program for Rare Pediatric Brainstem Tumor December 13, 2025
Search
Biotech
December 22, 2025
December 21, 2025
December 20, 2025
December 19, 2025
December 18, 2025
December 17, 2025
December 16, 2025
December 15, 2025
December 14, 2025
December 13, 2025
